Blood Coagulation & Fibrinolysis

Papers
(The median citation count of Blood Coagulation & Fibrinolysis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487Phe81
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination25
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy22
Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding19
Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays13
Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans11
New approaches to the genetic study of bleeding diathesis in our center: from sanger to next-generation sequencing11
An atypical presentation of catastrophic antiphospholipid syndrome with refractoriness to treatment11
Comparing fondaparinux and low molecular weight heparin for thromboprophylaxis after hip and knee arthroplasty: a systematic review and meta-analysis10
Current epidemiology of deaths for disseminated intravascular coagulation10
Obesity and physical exercise in hemophilia9
Predictive value of miR-24-3p and miR-1277-5p in hemodialysis patients with vascular access thrombosis9
Clot waveform analysis in hemophilia carriers9
Exploring the antioxidant and antithrombotic potential of Tetraclinis articulata: an in-vitro investigation on human blood9
Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays8
A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream8
Disability and the social impact of hemophilia7
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency7
Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant7
The determination of euglobulin clot lysis time reference intervals in Beckton Dickinson and Kima 3.2% sodium citrate coagulation tubes7
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome7
Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab7
Genetic and clinical characterization of factor VII deficiency: insights from 34 Turkish patients7
Time-in-therapeutic range falls as the target international normalized ratio range increases in patients on warfarin7
Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis6
The procoagulant potential before and after surgery for endometriosis and its association with disease severity6
Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease6
The physiology of hemostasis6
Venous thromboembolism secondary prophylaxis in elderly people (over 75 years old) with low-dose direct oral anticoagulants5
Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus5
Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients5
Endotoxemia-induced protein C surge protects mice against venous thrombosis based on transient lowering of natural anticoagulants5
Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population5
Safety of Sinopharm vaccine in patients with congenital bleeding disorders under on-demand therapy: a preliminary report5
Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy5
Rare coagulation factor deficiencies: a five-year experience from a single tertiary care center in South India5
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis4
Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism4
Why do patients with antiphospholipid syndrome bleed? A clinical paradox4
Factor VIII beyond haemophilia: a hidden regulator of venous thrombosis and endothelial dysfunction4
A novel FGG variant associated with hereditary hepatic fibrinogen storage disease from Adana4
Acquired factor XIII deficiency is associated with mortality and is not linked to hypocalcemia4
A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency4
An alternative method to assess the long-term stability of frozen plasmas for coagulation testing4
Harmonizing factor assay-related testing performed in a large laboratory network4
Anticoagulant and antiplatelet activity of aqueous extracts of Citrus sinensis and Lippia alba: interactions and potential for the development of antithrombotics4
Is the combination of two automated rapid assays for diagnosis of heparin-induced thrombocytopenia necessary?4
Haploidentical stem cell transplantation in DOCK8 deficiency: a case report of successful outcomes4
Fibrinogen reflects severity and predicts outcomes in patients with sepsis and septic shock4
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations3
Evaluation of a 4 min 4000g centrifugation protocol for routine coagulation assays3
Association between thrombophilic gene variants and thrombosis in the Iranian population: a systematic review and meta-analysis3
Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient3
Advances in nanotechnology for synthetic polymer hemostats: navigating precision hemostasis3
Two patients with protein S deficiency and cerebral venous sinus thrombosis: nonsense mutations of the PROS1 gene may account for these deficiencies3
Performance evaluation of the Sysmex CN-6000-automated coagulation analyzers for routine coagulation tests3
Congenital factor V deficiency in Taiwan: identification of a novel variant p.Tyr1813∗ and two variants specific to East Asians3
Lupus anticoagulant hypoprothrombinemia syndrome with multiple and high-titer antiphospholipid antibodies strongly interfered with coagulation assays3
Hemolysis detection accuracy on Stago sthemO 3013
Analysis of heparin-induced thrombocytopenia diagnostic and management strategies in individuals with inconclusive antibody optical densities3
A rare case of essential thrombocythemia with pseudo-hyperkalemia3
Tissue factor-dependent coagulation activation in intracranial neoplasms: a comparative study3
The factor V H1327R (rs1800595) polymorphism is associated with venous thromboembolic events: a case–control study in southern Iran3
Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment3
CRISPR/Cas9 mediated generation of zebrafish f9a mutant as a model for hemophilia B3
Presentation of concurrent thrombotic thrombocytopenic purpura and Graves’ disease2
Hemostatic parameters predict 90-day mortality in hospitalized cirrhotic patients with acute decompensation: a prospective cohort study2
Safety and efficacy of thrombolytic interventions in the treatment of intermediate and high-risk pulmonary embolism2
Measuring coagulopathy in pediatric craniofacial surgery2
Adrenal insufficiency revealing bilateral adrenal hemorrhage related to JAK2 V617F-positive essential thrombocythemia: about two cases2
The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage2
Warfarin versus direct oral anticoagulants in South Asian octogenarians: a retrospective review2
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada2
Characterization of zebrafish coagulation cofactors Fviii and Fv mutants and modeling hemophilia A and factor V deficiency2
Sustained good response to rituximab in acquired von Willebrand syndrome2
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding2
Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review2
Epidemiological study about the mental state of patients after a pulmonary embolism or deep venous thrombosis event2
Evaluation of coagulation parameters and impact of transfusion on coagulation in patients with beta thalassemia major2
Silent progression of hemophilic arthropathy of the elbow: case reports of three pediatric patients2
Effects of Momordica charantia exosomes on platelet activation, adhesion, and aggregation2
Interpreting coagulation mixing study results in the era of direct oral anticoagulants2
Thrombin generation assay: the present and the future2
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study2
Quantifying time from last dose: do direct oral anticoagulant assays correlate with patient's reported last dose2
Psychological complications among patients with congenital bleeding disorders2
Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII2
A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism2
Management of autoimmune factor XIII deficiency in a frail, elderly patient2
Disseminated intravascular coagulation in acute leukemia patients2
Hemostatic cover in orthopedic surgery2
Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience2
Bleeding disorders in Saudi Arabia, causes and prevalence: a review2
Molecular mechanism analysis of a family with hereditary coagulation FXI deficiency caused by compound heterozygous mutations2
Serum levels of inflammatory markers, sP-selectin, IL-1β, IL-6, and hsCRP are positively correlated with tissue factor transcript level of peripheral blood mononuclear cells in stroke2
Enhancing prediction of thrombosis associated with breast cancer using prechemotherapy hematologic and coagulation characteristics2
Clinical and economic implications of false-positive heparin-induced thrombocytopenia immunoassays: utility of the 4T score2
Hemorrhagic complications in individuals with liver disease submitted to minor oral surgery2
A challenging case of heparin-induced skin necrosis without thrombocytopenia2
The role of factor XIII in patient blood management1
Challenges in managing severe homozygous protein c deficiency: a case report1
Hereditary hepatic fibrinogen storage disease with a novel fibrinogen variant FGG c.1113T>A (fibrinogen Seoul III)1
The role of endothelial cell protein C receptor gene polymorphism in venous thromboembolic disease: a case report and literature review1
Evaluation of paediatric immune thrombocytopenia patients with clinical and laboratory findings: emphasizing the role of monocytosis1
Assessment of coagulation assays on Roche Cobas t711 analyzer: performance and clinical implications1
The most common disease-causing mutation of factor XIII deficiency is corrected by CRISPR/CAS9 gene editing system1
Hematological treatment and prophylaxis in patients with and without inhibitors1
Impact of cytochrome P-450 3A4 enzyme/P-glycoprotein inducing antiseizure medications on direct oral anticoagulant therapy1
Nonpharmacological treatment for coping with pain1
Severe acquired Factor VII deficiency complicating an aplastic anemia, successfully treated with corticosteroids1
Recessively inherited protein C deficiency in two sisters: intracerebral hemorrhage and coagulopathy complications1
Severe thrombocytopenia associated to bevacizumab in a patient with scleroderma, gastrointestinal angiodysplasias and refractory gastrointestinal bleeding1
Acquired factor XIII deficiency and its unprecedented association with multiple myeloma: case report and literature review1
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen1
4-Factor prothrombin complex concentrates and factor VIII inhibitor bypass activity use in cardiac surgery1
The role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as venous thromboembolism predictors in breast cancer patients pre- and post-therapy1
Endothelium-biomarkers for postthrombotic syndrome: a case–control study1
Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease1
Compound heterozygous mutations (p.L68R∗37 and p.T241N) lead to abnormal protein levels and structures in hereditary FVII deficiency1
Prolonged prothrombin time does not correlate with clinical bleeding symptoms in newly diagnosed paediatric leukaemia patients1
The impact of vascular endothelial glycocalyx on the pathogenesis and treatment of disseminated intravascular coagulation1
A contemporary approach to the musculoskeletal problems associated with hemophilia1
The coexistence of antiβ2 glycoprotein 1 antibody antibody has no effect on hemophilia A patient1
In vitro differential inhibition of the factor XI activity assay in the setting of a lupus anticoagulant1
A retrospective study on the use of low-molecular-weight heparin for prevention of pregnancy-related recurrent venous thromboembolism and obstetrical complications1
Coagulopathy following Crotaliπae snakebites in northeast Florida1
Platelet aggregation response in children with infantile haemangioma under propranolol treatment1
Association of hemostasis and inflammation biomarkers with outcomes in acute coronary syndromes1
New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9 min earlier1
Evaluation of D-dimer levels measured by different analytical methods in COVID-19 patients1
Efficacy of extended microthrombolysis in an elderly lady with purpura fulminans1
Noninvasive prenatal diagnosis of congenital factor XIII deficiency in Iran1
Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study1
The evaluation of reactive oxygen species generation and free mitochondrial DNA in platelet concentrates during 5 days of storage1
Comment on: coagulopathy following Crotaline snakebites in northeast Florida1
The impact of intrauterine growth on coagulation and factor XII function in preterm infants1
Whole blood thrombin generation hypercoagulable profile in a patient with hemolytic crisis due to paroxysmal nocturnal hemoglobinuria: a case report1
Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT1
New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants1
Clot waveform analysis in acute promyelocytic leukemia1
True vs. false immune-mediated thrombotic thrombocytopenic purpura exacerbations: a clinical case in the caplacizumab era1
Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice1
Evolutional development of the hemostasis laboratory and the treatment of hemophilia1
Assessment of risk factors for deep vein thrombosis associated with natural anticoagulants and fibrinolytic regulatory proteins1
Is dynamic change in mean platelet volume related with composite endpoint development after transcatheter aortic valve replacement?1
Individualizing primary prophylaxis in patients with hemophilia A and B, adherence and new products1
Management of gastrointestinal bleeding in a patient with type 3 von Willebrand disease and inhibitors to von Willebrand factor: a case report1
Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey: Erratum1
The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma1
Incidence of factor XII deficiency in critically ill patients with a prolonged activated partial thromboplastin time: a prospective observational study1
Human plasma-derived plasminogen replacement in type 1 plasminogen deficiency: a pediatric case with multisystemic manifestation1
Self-limited thrombotic thrombocytopenic purpura1
Acquired factor V and factor X Deficiency coexisting with acquired dysfibrinogenaemia in a patient with light chain myeloma1
Pharmacokinetics, efficacy and safety of a novel fibrinogen concentrate in pediatric patients with congenital afibrinogenemia1
Homozygous MTHFR C677T carriers develop idiopathic portal vein thrombosis 20 years earlier than wild type1
The predictive role of platelet count for bleeding in patients with hepatitis B virus and hepatitis C virus infection1
Comparison of bleeding and ischemic events with apixaban vs. rivaroxaban in triple antithrombotic therapy regimens1
Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates1
Prenatal diagnosis for hemophilia A (intron 22 inversion) reveals a rare association with Klinefelter syndrome with diagnostic difficulties in molecular interpretation1
The impact of neutrophil extracellular traps in coronavirus disease - 2019 pathophysiology1
Never too soon to be thinking about heparin-induced thrombocytopenia! A case report of early onset heparin-induced thrombocytopenia1
0.063376903533936